GLORIA ECHEVERRIA's research topics

GLORIA ECHEVERRIA

Concepts (94)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with GLORIA ECHEVERRIA's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that GLORIA ECHEVERRIA has written about over time.

Microsatellite Repeats, 1 publications between 2012 and 2012, average publication date February 2012. RNA-Binding Proteins, 3 publications between 2010 and 2013, average publication date April 2012. Alternative Splicing, 2 publications between 2010 and 2013, average publication date May 2012. Exons, 2 publications between 2010 and 2013, average publication date May 2012. Receptor, Insulin, 2 publications between 2010 and 2013, average publication date May 2012. Introns, 2 publications between 2013 and 2015, average publication date September 2014. Ribonucleoproteins, 2 publications between 2013 and 2015, average publication date September 2014. Neoplasm Metastasis, 3 publications between 2015 and 2018, average publication date November 2016. Breast Neoplasms, 2 publications between 2015 and 2020, average publication date April 2018. Xenograft Model Antitumor Assays, 6 publications between 2015 and 2020, average publication date August 2018. Cell Line, Tumor, 5 publications between 2015 and 2023, average publication date January 2019. Doxorubicin, 1 publications between 2019 and 2019, average publication date April 2019. Mice, SCID, 3 publications between 2018 and 2020, average publication date September 2019. Triple Negative Breast Neoplasms, 7 publications between 2016 and 2023, average publication date September 2020. Biomarkers, Tumor, 1 publications between 2020 and 2020, average publication date December 2020. Breast, 1 publications between 2020 and 2020, average publication date December 2020. Mammary Glands, Animal, 1 publications between 2020 and 2020, average publication date December 2020. Antineoplastic Agents, 2 publications between 2020 and 2023, average publication date December 2021. Neoadjuvant Therapy, 3 publications between 2019 and 2023, average publication date December 2021. Cancer-Associated Fibroblasts, 1 publications between 2023 and 2023, average publication date November 2023.

Microsatellite Repeats
RNA-Binding Proteins
Alternative Splicing
Exons
Receptor, Insulin
Introns
Ribonucleoproteins
Neoplasm Metastasis
Breast Neoplasms
Xenograft Model Antitumor Assays
Cell Line, Tumor
Doxorubicin
Mice, SCID
Triple Negative Breast Neoplasms
Biomarkers, Tumor
Breast
Mammary Glands, Animal
Antineoplastic Agents
Neoadjuvant Therapy
Cancer-Associated Fibroblasts

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Microsatellite Repeats	1	2012	2012	February 2012
RNA-Binding Proteins	3	2010	2013	April 2012
Alternative Splicing	2	2010	2013	May 2012
Exons	2	2010	2013	May 2012
Receptor, Insulin	2	2010	2013	May 2012
Introns	2	2013	2015	September 2014
Ribonucleoproteins	2	2013	2015	September 2014
Neoplasm Metastasis	3	2015	2018	November 2016
Breast Neoplasms	2	2015	2020	April 2018
Xenograft Model Antitumor Assays	6	2015	2020	August 2018
Cell Line, Tumor	5	2015	2023	January 2019
Doxorubicin	1	2019	2019	April 2019
Mice, SCID	3	2018	2020	September 2019
Triple Negative Breast Neoplasms	7	2016	2023	September 2020
Biomarkers, Tumor	1	2020	2020	December 2020
Breast	1	2020	2020	December 2020
Mammary Glands, Animal	1	2020	2020	December 2020
Antineoplastic Agents	2	2020	2023	December 2021
Neoadjuvant Therapy	3	2019	2023	December 2021
Cancer-Associated Fibroblasts	1	2023	2023	November 2023

ECHEVERRIA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (94)

Explore

Co-Authors (22)

Explore

Similar People (60)

Explore

Same Department

Explore